ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,359Medicare Part D Prescriptions Filled, Including Refills

Rank: 340 out of 2170

$520K Total Retail Price of All Prescriptions

Rank: 423 out of 2170

412 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 412 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 412 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 7,686 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
LEVOTHYROXINE SODIUM 574 520 1 5
LISINOPRIL 442 355 2 3
SIMVASTATIN 437 322 3 1
METFORMIN HCL 418 326 4 8
OMEPRAZOLE 299 201 5 2
ZOLPIDEM TARTRATE 280 196 6 17
HYDROCODONE-ACETAMINOPHEN 279 144 S3 7 7
AMLODIPINE BESYLATE 269 225 8 4
MELOXICAM 216 122 9 28
TRAMADOL HCL 203 166 10 18
ATENOLOL 190 154 11 23
PRAVASTATIN SODIUM 185 152 12 11
GABAPENTIN 170 122 13 14
FUROSEMIDE 158 134 14 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 106 15 20
GLIMEPIRIDE 152 128 16 31
CARVEDILOL 139 122 17 26
LOSARTAN POTASSIUM 137 113 18 21
SYNTHROID 135 126 19 27
HYDROCHLOROTHIAZIDE 124 83 20 9
NEXIUM 123 101 21 22
CITALOPRAM HBR 121 78 22 19
FENOFIBRATE 120 94 23 57
FLUOXETINE HCL 119 75 24 59
ATORVASTATIN CALCIUM 109 91 25 12
WARFARIN SODIUM 106 94 26 15
METOPROLOL TARTRATE 106 85 26 10
TRAZODONE HCL 94 64 28 38
PAROXETINE HCL 92 88 29 65
LOSARTAN-HYDROCHLOROTHIAZIDE 87 73 30 42
CRESTOR 84 61 31 24
ALLOPURINOL 79 77 32 29
CLOPIDOGREL 78 63 33 37
DOXYCYCLINE HYCLATE 77 52 34 100
TAMSULOSIN HCL 77 56 34 33
ISOSORBIDE MONONITRATE ER 69 48 36 50
RANITIDINE HCL 68 41 37 40
POTASSIUM CHLORIDE 68 39 37 16
PANTOPRAZOLE SODIUM 62 55 39 39
SERTRALINE HCL 62 34 39 25
LEVOXYL 60 36 41 115
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 45 42 116
DOXAZOSIN MESYLATE 59 59 42 93
PLAVIX 59 50 42 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 45 45 95
AZITHROMYCIN 57 40 46 47
CARBIDOPA-LEVODOPA 51 34 47 110
METOPROLOL SUCCINATE 50 44 48 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.